Chair and Department Executive Officer of the Department of Internal Medicine and Director of the Fraternal Order of Eagles Diabetes Research Center (FOEDRC) at the University of Iowa
E. Dale Abel, MD, PhD is the Chair and Department Executive Officer of the Department of Internal Medicine and Director of the Fraternal Order of Eagles Diabetes Research Center (FOEDRC) at the University of Iowa. He is a Professor of Medicine, of Biochemistry, and of Biomedical Engineering, and holds the John B. Stokes III Chair in Diabetes Research and the François M. Abboud Chair in Internal Medicine.
Dr. Abel has had a distinguished career in endocrine and metabolism research. His pioneering work on glucose transport and mitochondrial metabolism in the heart guides his current research interests: molecular mechanisms responsible for cardiovascular complications of diabetes. His laboratory has provided important insights into the contribution of mitochondrial dysfunction and aberrant insulin signaling, to heart failure risk in diabetes. Recent work has focused on mitochondrial mechanisms that mediate inter-organ crosstalk that may influence the pathophysiology of insulin resistance and mitochondrial pathways linking metabolism with increased risk for atherothrombosis.
Dr. Abel’s research program has been continually funded by the National Institutes of Health since 1995, and by the American Heart Association, the American Diabetes Association, and the Juvenile Diabetes Research Foundation. Dr. Abel is the recipient of numerous awards for scholarship and mentorship. He is an elected member of the American Association of Physicians (AAP), the American Society for Clinical Investigation (ASCI), National Academy of Medicine (NAM), and the American Clinical and Climatological Association (ACCA). Dr. Abel is the 2018-2019 Endocrine Society President.
Professor of Medicine and Director of the Benign Thyroid Disorders Program at The Ohio State University
Jennifer A. Sipos is a Professor of Medicine and Director of the Benign Thyroid Disorders Program at The Ohio State University. She obtained her medical degree and received her Internal Medicine residency training at Wake Forest University. She completed her Endocrinology and Metabolism fellowship at the University of North Carolina in Chapel Hill. Dr. Sipos has developed an interest in the use of ultrasonography for the diagnosis and management of thyroid cancer and has taught and served as a course director for numerous ultrasound courses nationally and internationally, including meetings for the Endocrine Society, American Thyroid Association, European Thyroid Association, American Association for Clinical Endocrinologists, Asia and Oceania Thyroid Association, Indian Endocrine Society, and International Society of Endocrinology. Additionally, she is actively involved in several clinical research projects with a particular interest in factors implicated in the development of salivary damage after radioiodine therapy. She also participates in clinical trials for the evaluation of multikinase inhibitor therapies in refractory thyroid cancer and the diagnostic use of molecular markers in thyroid nodules.
Professor of Endocrinology
Presbiterian Medical Center
Columbia University - New York - USA
Dr. Bilezikian, the Dorothy L. and Daniel H. Silberberg Professor of Medicine and Professor of Pharmacology at the College of Physicians & Surgeons, Columbia University is Chief of the Division of Endocrinology and Director of the Metabolic Bone Diseases Program at Columbia University Medical Center. Dr. Bilezikian received his undergraduate training at Harvard College and his medical training at the College of Physicians & Surgeons. He completed four years of house staff training (internship, residency and Chief Residency) on the Medical Service at Columbia Presbyterian Medical Center. Dr. Bilezikian received his training in Metabolic Bone Diseases and in Endocrinology at the NIH in the Mineral Metabolism Branch under the tutelage of Dr. Gerald Aurbach.
Dr. Bilezikian belongs to a number of professional societies including the American Society for Bone and Mineral Research, of which he served as President, 1995-1996 and the International Society of Clinical Densitometry, of which he served as President, 1999-2001. He is a member of the Endocrine Society, the American Federation for Clinical Research, the American Society for Clinical Investigation, the Association of American Physicians, the American Association of Clinical Endocrinologists, the American Society for Pharmacology and Experimental Therapeutics, and the American College of Endocrinology that has designated him Master. He is Chair of the Endocrine Fellows Foundation. He served as Editor-in-Chief of the Journal of Clinical Endocrinology and Metabolism (2000-2004). He is Senior Associate Editor of the Journal of Bone and Mineral Research (2008- ). His books include Editor-in-Chief of The Parathyroids (1994, 2001), and co-editor of The Aging Skeleton (1999), Dynamics of Bone and Cartilage Metabolism (1999, 2006), and Principles of Bone Biology (1996, 2002, 2008) and Osteoporosis in Men (2010).
He has been on numerous panels, including serving as Chair of the NIH Consensus Development Panel on Optimal Calcium Intake (1994) and Co-chair of the last two NIH Workshops on Primary Hyperparathyroidism (2002, 2008). He is a major national and international spokesperson for the field of metabolic bone diseases. Dr. Bilezikian's major research interests are related to the clinical investigation of metabolic bone diseases, particularly osteoporosis and primary hyperparathyroidism. He is the recipient of the Distinguished Physician Award of the Endocrine Society, the Frederic C. Bartter Award of the American Society for Bone and Mineral Research (ASBMR) for Excellence in Clinical Research, the John P. McGovern Compleat Physician Award of the Houston Academy of Medicine, the First Annual Global Leadership Award of the International Society of Clinical Densitometry, and Lifetime Achievement Awards of the Armenian American Medical Society of California and the Armenian American Health Professionals Organization. In 2009, he received the Gideon A. Rodan Excellence in Mentorship Award from the ASBMR. His publications, which number over 600, speak to his active original investigative initiatives as well as his authorship of many reference sources of endocrinology and metabolic bone diseases.
Professor of Medicine, Division of Endocrinology, Metabolism & Diabetes
Associate Director, Anschutz Health & Wellness Center
University of Colorado School of Medicine
Dr. Cornier has been on faculty at the University of Colorado with the Division of Endocrinology, Metabolism and Diabetes since 2001, where he is currently a Professor of Medicine. Prior to that he received his undergraduate education at Vanderbilt University in Biomedical Engineering. He then attended the Medical College of Georgia where he received his medical degree. He went on to do his medical residency at Georgetown University Medical Center and followed this with a fellowship in endocrinology at the University of Colorado Health Sciences Center. Dr. Cornier is currently the Associate Director and Medical Director of the Anschutz Health and Wellness Center. He also runs a lipid and a diabetes clinic at the University of Colorado Hospital. Dr. Cornier is an active clinical and translational investigator with a primary research interest in understanding the complex regulation of food intake, body weight and metabolism. Dr. Cornier has been a very active volunteer in important health-related associations, including the Endocrine Society, American Diabetes Association, Obesity Society, and American Heart Association.